a nonsignificant trendP = 0.13
For all eligible patients ( n = 94), there was a nonsignificant trend to an increased risk in mortality in the etomidate group (adjusted OR: 4.8, 95% CI: 0.6–35.9, P = 0.13).
For all eligible patients ( n = 94), there was a nonsignificant trend to an increased risk in mortality in the etomidate group (adjusted OR: 4.8, 95% CI: 0.6–35.9, P = 0.13).